A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Exclusion Criteria

• •Prior history of herpes zoster.
• •Prior history of vaccination with herpes zoster vaccine or chickenpox vaccine.
• •History of allergic disease likely to be exacerbated by any component of the vaccine.
• •Taking immunoglobulins and/or any blood products within the last 3 months or will receive these products during the study period.
• •Taking certain pharmaceuticals to be like salicylate kind, including aspirin, and difluorosalicylic, or going to take these medicine during the study period.
• •Participation in another research study involving receipt of an investigational product in the last 30 days.
• •Prior administration of live vaccine in last 30 days.
• •Prior administration of subunit vaccine, inactivated vaccine or allergic therapy in last 14 days.
• •History of serious disease and the participation in the clinical trial is likely to increase the disease risk and interfere with the observation of clinical trial index.
• •Taking immunosuppressive therapy in last 6 months.
• •Any autoimmune disease or immunodeficient state, autoimmune disease or immunodeficient disease.
• •Active tuberculosis patient.
• •Acute or chronic infections at the vaccination day (axillary temperature≥ 38.0°C).
• •Coagulation disorders (coagulation factor deficiency, coagulopathy or platelet disorder) diagnosed by doctors, or obvious bruises or blood coagulation noticed.
• •Woman who is breast-feeding.
• •Previous history of mental and neurological diseases (e.g. depression, epilepsy or convulsion)
• •Planned to move before the end of the study or leave the country for a long time during the scheduled study visit.
• •Abnormal Blood Routine and Biochemical Indexes before Inoculation (except for minor abnormalities that are not clinically significant as judged by doctors)
• •Any other conditions may compromise the safety or availability of participants in the judgment of the investigator.